tiprankstipranks
Trending News
More News >
Advertisement

DMXF - ETF AI Analysis

Compare

Top Page

DMXF

iShares ESG Advanced MSCI EAFE ETF (DMXF)

Rating:65Neutral
Price Target:
$81.00
The iShares ESG Advanced MSCI EAFE ETF (DMXF) has a solid overall rating, driven by strong contributions from holdings like Novartis AG and ASML Holding NV. Novartis stands out for its robust profitability, stable balance sheet, and growth in key products, while ASML benefits from strong revenue and profit growth despite being slightly expensive. However, weaker holdings like SoftBank Group, with its mixed financial performance and cash flow challenges, may have slightly held back the fund’s rating. A potential risk factor is the ETF's concentration in a few high-performing stocks, which could impact diversification.
Positive Factors
Strong Top Holdings
Several key positions, such as ASML Holding and Spotify, have delivered strong year-to-date performance, supporting the fund's overall returns.
Low Expense Ratio
The ETF charges a very low expense ratio, making it cost-effective compared to many other funds.
Broad Geographic Exposure
The fund is diversified across multiple countries, including Japan, France, and Switzerland, reducing reliance on any single economy.
Negative Factors
Underperforming Holding
SAP SE, one of the top holdings, has shown negative year-to-date performance, which could drag on the fund's overall returns.
Sector Concentration Risk
The ETF has heavy exposure to the financial and technology sectors, which could make it vulnerable to downturns in these industries.
Limited U.S. Exposure
With only 5.93% allocated to U.S. companies, the fund may miss out on opportunities in the world's largest economy.

DMXF vs. SPDR S&P 500 ETF (SPY)

DMXF Summary

The iShares ESG Advanced MSCI EAFE ETF (DMXF) is an investment fund that focuses on companies in developed markets outside North America, such as Europe, Japan, and Australia, while prioritizing environmental, social, and governance (ESG) standards. It tracks the MSCI EAFE Choice ESG Screened Index, which excludes businesses involved in controversial industries. Some of its top holdings include well-known companies like ASML Holding NV and SAP SE. Investors might consider DMXF for global diversification and the opportunity to support sustainable practices. However, since it focuses on international markets, its performance can be affected by global economic conditions and currency fluctuations.
How much will it cost me?The iShares ESG Advanced MSCI EAFE ETF (DMXF) has an expense ratio of 0.12%, meaning you’ll pay $1.20 per year for every $1,000 invested. This is lower than average because it’s passively managed, tracking an index rather than relying on active stock picking.
What would affect this ETF?The DMXF ETF, focused on developed markets outside North America and emphasizing ESG principles, could benefit from increasing global interest in sustainable investing and growth in sectors like technology and healthcare, which are heavily represented in its holdings. However, it may face challenges from economic slowdowns in Europe or Asia, regulatory changes affecting ESG criteria, or sector-specific risks such as volatility in financials and technology. Investors should also consider how currency fluctuations in non-North American markets might impact returns.

DMXF Top 10 Holdings

The iShares ESG Advanced MSCI EAFE ETF is leaning heavily on financials and technology, with names like ASML Holding NV providing steady gains year-to-date despite mixed short-term momentum. Novartis AG in healthcare is another bright spot, showing resilience with bullish trends and solid fundamentals. However, SAP SE has been lagging, dragging on performance with bearish technicals and weaker recent returns. SoftBank Group’s mixed results add a layer of unpredictability, while Schneider Electric’s positive trend is tempered by valuation concerns. Overall, the fund’s developed-market focus offers a diverse mix, but financials dominate the narrative.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV4.48%$28.53M€328.05B34.84%
76
Outperform
SAP SE2.92%$18.59M€242.18B-8.13%
66
Neutral
Novartis AG2.86%$18.19MCHF196.03B12.04%
80
Outperform
Schneider Electric1.67%$10.65M€125.49B-7.69%
62
Neutral
Air Liquide1.31%$8.33M€94.92B2.39%
66
Neutral
ABB Ltd1.26%$8.03Mkr1.20T11.59%
78
Outperform
EssilorLuxottica SA1.26%$8.00M€140.29B29.07%
68
Neutral
AIA Group1.25%$7.98MHK$827.43B42.26%
72
Outperform
SoftBank Group1.25%$7.94M$155.43B91.87%
55
Neutral
Sumitomo Mitsui Financial Group1.24%$7.86M¥17.11T23.48%
79
Outperform

DMXF Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
76.21
Negative
100DMA
75.22
Negative
200DMA
72.23
Positive
Market Momentum
MACD
-0.66
Positive
RSI
40.82
Neutral
STOCH
20.80
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DMXF, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 76.00, equal to the 50-day MA of 76.21, and equal to the 200-day MA of 72.23, indicating a neutral trend. The MACD of -0.66 indicates Positive momentum. The RSI at 40.82 is Neutral, neither overbought nor oversold. The STOCH value of 20.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DMXF.

DMXF Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$639.47M0.12%
65
Neutral
$967.61M0.30%
65
Neutral
$898.58M0.20%
66
Neutral
$831.31M0.39%
65
Neutral
$711.13M0.42%
67
Neutral
$604.65M0.28%
65
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DMXF
iShares ESG Advanced MSCI EAFE ETF
74.34
9.54
14.72%
QEFA
SPDR MSCI EAFE StrategicFactors ETF
GSID
Goldman Sachs MarketBeta International Equity ETF
JHMD
John Hancock Multifactor Developed International ETF
IQDG
WisdomTree International Quality Dividend Growth Fund
NUDM
Nuveen ESG International Developed Markets Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement